Floatz logo

BMS-986345

Peripheral T-Cell Lymphoma, Not Otherwise Specified

City of Hope Medical CenterPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
89/ 100

Competitive context

7 Active assets in the Peripheral T-Cell Lymphoma, Not Otherwise Specified cohort.

Asset / SponsorPhaseRating
ETOPOSIDE
City of Hope Medical Center
Phase 4BB
Inno-206
BeBetter Med Inc
Phase 2BB
VINCRISTINE SULFATE
BeBetter Med Inc
Phase 2BB
Soquelitinib
Corvus Pharmaceuticals, Inc.
Phase 3B
Auto4
Autolus Limited
Phase 1/2CC
q702
Mayo Clinic
Phase 1CC
Ruxolitinib Phosphate
City of Hope Medical Center
Phase 1CC
FLUDEOXYGLUCOSE
City of Hope Medical Center
Phase 1CC

Same molecule, other indications

BMS-986345 is also rated in:

Chronic Lymphocytic LeukemiaDormant
B
Indicative ·
58 / 100
View asset →
Follicular LymphomaDormant
B
Indicative ·
56 / 100
View asset →
Indolent Non-Hodgkin LymphomaDormant
B
Indicative ·
56 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →